The epidemiology of infections associated with orthotopic liver transplantation is summarized herein, and approaches to prophylaxis are outlined. Infection is a major complication following orthotopic liver transplantation, and more than half of transplant recipients develop at least one infection. The risk of infection is highest in the first month after transplantation, and the most common pathogens are bacteria and cytomegalovirus (CMV). Bacterial infections usually occur in the first month, arise in the abdomen, and are caused by aerobes. The peak incidence of CMV infection is late in the first month and early in the second month after transplantationn. CMV syndromes include fever and neutropenia, hepatitis, pneumonitis, gut ulceration, and disseminated infection. Other significant problems are Candida intraabdominal infection, Herpes simplex mucocutaneous infection or hepatitis, adenovirus hepatitis, and Pneumocystis carinii pneumonia.
considering either empiric treatment of suspected infection or approaches to prophylaxis.
BACTERIAL INFECTION Infection Rates
Rates of bacterial infection following OLT vary considerably, as shown by the results from selected centers summarized in Table 1 . The average number of infections ranged from 0.51 to 2.0 infection per patient, and the percentage of patients experiencing at least one bacterial infection ranged from 36% to 68%. Differences in rates probably are attributable to several factors. First, definitions of infections sometimes were not stated and apparently varied. One group apparently included positive cultures of vascular catheters, bile, and urine as infections3, while another group included only major infections having serious associated morbidity in most of their tabulations Second, patient populations may have differed in terms of underlying hepatic disease and in severity of illness at the time of transplantation. These characteristics were not described in some series, even though a possible role is suggested by the finding at one center that infection rates were higher in patients with hepatocellular disease than in those with cholestatic disease1. Third, bacterial prophylaxis differed at the various centers. Four centers administered intravenous cefotaxime, but the regimens varied in cefotaxime duration, choice of other systemic antibiotics, and use of oral agents for bowel decontamination. The center with the second highest rate of bacterial infection used only perioperative cefoxitin. Adoption of a selective bowel decontamination (SBD) regimen by the center reporting the lowest rate of bacterial infection may be a significant advance9. SBD regimens utilize oral non-absorbable agents selected for their activity against aerobic enteric gram-negative bacilli and Candida. These regimens have limited activity against gut anaerobes, whose preservation can impede colonization of the alimentary tract by the more pathogenic aerobes that have been important pathogens in infections following OLT1.
Epidemiology
Most bacterial infections occurred in the first month after OLT1-5, and the incidence of bacterial infection declined steadily thereafter. The most common site of infection was the abdomen, as shown in Table 2 . Other major sites of infection were primary bacteremia, pneumonia, and surgical wound infection. The surgical procedure itself and technical complications account for the predominant role of abdominal infections. In one series, episodes of peritonitis were associated with biliary leaks, cholangitis was associated with biliary duct stricture, and liver abscesses were associated with technical problems involving the implanted liver1.
Bloodstream infections for which no primary source was apparent ranked second in frequency. It has been speculated that these infections originate in the abdomen1'5, presumably as a consequence of unrecognized primary infection or bacterial translocation. Secondary bacteremia, typically arising from an identified abdominal site1'4"5, also occurred commonly but is not listed in Table 2 . Bacterial pneumonia was a less frequent problem, but in one series the mortality was 40%1. 
VIRAL INFECTION Cytomegalovirus
In liver transplant recipients, cytomegalovirus (CMV) is the most frequent cause of serious viral infection and often is the most common individual pathogen of any type2-4'11. Clinically significant CMV infection has been reported in about onefourth of patients1'2'4'11-14, as summarized in Table 3 . An additional one-fourth of patients have serological evidence of CMV infection that is asymptomatic4'11 '12. CMV infection has been detected as early as the first week after transplantation4, but most cases occurred late in the first month or early in the second month following transplantation4 '11-14. The clinical manifestations of CMV infection are diverse, and each manifestation has a spectrum of severity. The most common presentation is a "viral syndrome" characterized by fever 
